<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>BiG生物创新社 | wechat-feeds</title><link>http://MzkxNTA5NjM1OA.favicon.privacyhide.com/favicon.ico</link><description>BiG, Biologics Innovation Group. To nurture an Eco-system for Biologics innovation and imprint China on Global map.</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 04 Jun 2021 18:23:54 +0800</pubDate><image><url>http://MzkxNTA5NjM1OA.favicon.privacyhide.com/favicon.ico</url><title>BiG生物创新社 | wechat-feeds</title><link>http://MzkxNTA5NjM1OA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>对话沈琳：从PI视角看双抗在胃肠肿瘤的疗效和难点</title><link>https://mp.weixin.qq.com/s/AYXhZuQhs4IbO0vIT689Ew</link><description></description><content:encoded><![CDATA[对话沈琳：从PI视角看双抗在胃肠肿瘤的疗效和难点]]></content:encoded><pubDate>Fri, 04 Jun 2021 18:19:15 +0800</pubDate></item><item><title>VEGFR-2单抗的进阶多面杀癌之路</title><link>https://mp.weixin.qq.com/s/BzM4p5_9uQB_LpGlfubMYQ</link><description></description><content:encoded><![CDATA[VEGFR-2单抗的进阶多面杀癌之路]]></content:encoded><pubDate>Fri, 04 Jun 2021 18:19:15 +0800</pubDate></item><item><title>肿瘤免疫明星靶点之CD137：双抗及Combo策略</title><link>https://mp.weixin.qq.com/s/YdR1b6qq0NWLT_qLzFHKPg</link><description></description><content:encoded><![CDATA[肿瘤免疫明星靶点之CD137：双抗及Combo策略]]></content:encoded><pubDate>Thu, 03 Jun 2021 16:04:44 +0800</pubDate></item><item><title>招聘｜董晨院士领衔，上海市免疫治疗创新研究院广募英才！</title><link>https://mp.weixin.qq.com/s/qgoAFZjnTwTvdbkzUZh3eg</link><description></description><content:encoded><![CDATA[招聘｜董晨院士领衔，上海市免疫治疗创新研究院广募英才！]]></content:encoded><pubDate>Thu, 03 Jun 2021 16:04:44 +0800</pubDate></item><item><title>四种靶向肿瘤相关巨噬细胞的策略</title><link>https://mp.weixin.qq.com/s/QyUe5OhxSGqo9JYlXx0fXA</link><description></description><content:encoded><![CDATA[四种靶向肿瘤相关巨噬细胞的策略]]></content:encoded><pubDate>Wed, 02 Jun 2021 17:45:44 +0800</pubDate></item><item><title>License-in重磅药，搅动研发格局！</title><link>https://mp.weixin.qq.com/s/54j2e45o0Jg_UGtVEx6AVw</link><description></description><content:encoded><![CDATA[License-in重磅药，搅动研发格局！]]></content:encoded><pubDate>Wed, 02 Jun 2021 17:45:44 +0800</pubDate></item><item><title>新药论坛三箭齐发，吐槽大会爆笑江湖｜BiG年会DAY 2</title><link>https://mp.weixin.qq.com/s/xQolJgZbYKTqNpZ5ovgnKA</link><description></description><content:encoded><![CDATA[新药论坛三箭齐发，吐槽大会爆笑江湖｜BiG年会DAY 2]]></content:encoded><pubDate>Tue, 01 Jun 2021 06:58:13 +0800</pubDate></item><item><title>从AMG510加速上市，看KRAS-不可成药靶点的逆袭之路！</title><link>https://mp.weixin.qq.com/s/Bpdqk8GR566u0nSeGzXY5Q</link><description></description><content:encoded><![CDATA[从AMG510加速上市，看KRAS-不可成药靶点的逆袭之路！]]></content:encoded><pubDate>Mon, 31 May 2021 17:34:04 +0800</pubDate></item><item><title>张文宏领衔燃BiG，八位研发掌门人再决BB-King之巅｜年会DAY1</title><link>https://mp.weixin.qq.com/s/5Blg-JmmoWFneysMBn7IwQ</link><description></description><content:encoded><![CDATA[张文宏领衔燃BiG，八位研发掌门人再决BB-King之巅｜年会DAY1]]></content:encoded><pubDate>Sun, 30 May 2021 10:26:32 +0800</pubDate></item><item><title>江河入海，东海论药！第七届BiG年会终极预告</title><link>https://mp.weixin.qq.com/s/aTKc113cxfe31o3j1pBuAA</link><description></description><content:encoded><![CDATA[江河入海，东海论药！第七届BiG年会终极预告]]></content:encoded><pubDate>Thu, 27 May 2021 12:52:34 +0800</pubDate></item><item><title>里程碑丨碧博生物药CDMO平台临港一期工程交付！</title><link>https://mp.weixin.qq.com/s/XnQrqE_ZbszUD3qVMY_JFg</link><description></description><content:encoded><![CDATA[里程碑丨碧博生物药CDMO平台临港一期工程交付！]]></content:encoded><pubDate>Wed, 26 May 2021 18:51:21 +0800</pubDate></item><item><title>“展”放光彩｜30+支持机构邀你打卡BiG七周年</title><link>https://mp.weixin.qq.com/s/2497boolFA7wJh24JC-84A</link><description></description><content:encoded><![CDATA[“展”放光彩｜30+支持机构邀你打卡BiG七周年]]></content:encoded><pubDate>Wed, 26 May 2021 18:51:21 +0800</pubDate></item><item><title>新药发现 | 更多伯乐还是更多千里马？</title><link>https://mp.weixin.qq.com/s/tS9nTUKpreJx4hnuif9alg</link><description></description><content:encoded><![CDATA[新药发现 | 更多伯乐还是更多千里马？]]></content:encoded><pubDate>Tue, 25 May 2021 17:20:32 +0800</pubDate></item><item><title>新江湖 | 鼎新基因加入BiG会员机构！</title><link>https://mp.weixin.qq.com/s/-kWli2FEtw-ChcHC-VLtZQ</link><description></description><content:encoded><![CDATA[新江湖 | 鼎新基因加入BiG会员机构！]]></content:encoded><pubDate>Tue, 25 May 2021 17:20:32 +0800</pubDate></item><item><title>中国生物药研发：PD-1之困，FIC之惑</title><link>https://mp.weixin.qq.com/s/W5Qja0xXC-gwjnebPXRJWw</link><description></description><content:encoded><![CDATA[中国生物药研发：PD-1之困，FIC之惑]]></content:encoded><pubDate>Tue, 25 May 2021 17:20:32 +0800</pubDate></item><item><title>创药蓝海风向标！BiG七周年即将倚天出鞘</title><link>https://mp.weixin.qq.com/s/_Y7eOYd_W8dsGAYUu3D-0A</link><description></description><content:encoded><![CDATA[创药蓝海风向标！BiG七周年即将倚天出鞘]]></content:encoded><pubDate>Mon, 24 May 2021 17:51:21 +0800</pubDate></item><item><title>近亿元A轮融资！祝贺抗体发现CRO-百英生物</title><link>https://mp.weixin.qq.com/s/Ot8azyC-d1DV4YJlBhwzMA</link><description></description><content:encoded><![CDATA[近亿元A轮融资！祝贺抗体发现CRO-百英生物]]></content:encoded><pubDate>Mon, 24 May 2021 17:51:21 +0800</pubDate></item><item><title>先声药业将于2021 ASCO年会公布多项抗肿瘤药物临床进展</title><link>https://mp.weixin.qq.com/s/bFzDrawgt1LhYmUozBdUSA</link><description></description><content:encoded><![CDATA[先声药业将于2021 ASCO年会公布多项抗肿瘤药物临床进展]]></content:encoded><pubDate>Mon, 24 May 2021 17:51:21 +0800</pubDate></item></channel></rss>